Published in J Virol on March 01, 1990
The molecular population genetics of HIV-1 group O. Genetics (2004) 4.53
Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med (2011) 2.98
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol (1994) 2.88
Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol (1994) 2.29
Going wild: lessons from naturally occurring T-lymphotropic lentiviruses. Clin Microbiol Rev (2006) 2.28
Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. J Virol (1994) 2.06
Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol (1995) 1.99
Structural features in TAR RNA of human and simian immunodeficiency viruses: a phylogenetic analysis. Nucleic Acids Res (1992) 1.74
Recombinant viruses and early global HIV-1 epidemic. Emerg Infect Dis (2004) 1.42
Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target. J Clin Microbiol (1999) 1.20
One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AG. J Clin Microbiol (2001) 1.06
Non-M variants of human immunodeficiency virus type 1. Clin Microbiol Rev (2013) 1.05
Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1. J Virol (1998) 1.04
Glucocorticoid receptor-binding site in the human immunodeficiency virus long terminal repeat. J Virol (1992) 1.04
Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections. J Clin Microbiol (2009) 0.97
Detection of genetically diverse human immunodeficiency virus type 1 group M and O isolates by PCR. J Clin Microbiol (1997) 0.95
Rapid assay for simultaneous detection and differentiation of immunoglobulin G antibodies to human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2. J Clin Microbiol (1998) 0.92
Origin and diversity of human retroviruses. AIDS Rev (2014) 0.92
Raised levels of tumour necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected patients from Ethiopia. Clin Exp Immunol (1993) 0.90
Performance of a multiplex qualitative PCR LCx assay for detection of human immunodeficiency virus type 1 (HIV-1) group M subtypes, group O, and HIV-2. J Clin Microbiol (2000) 0.89
Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs. BMC Microbiol (2010) 0.84
Measurement of levels of human immunodeficiency virus type 1 reverse transcriptase (RT) and RT activity-blocking antibody in human serum by a new standardized colorimetric assay. J Clin Microbiol (1997) 0.82
HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges. Infect Genet Evol (2015) 0.80
Segregation of human immunodeficiency virus type 1 subtypes by risk factor in Australia. J Clin Microbiol (2003) 0.80
A highly heterogeneous HIV-1 epidemic in the Central African Republic. Emerg Infect Dis (1996) 0.79
Recombinant viruses initiated the early HIV-1 epidemic in Burkina Faso. PLoS One (2014) 0.78
Comparison of predicted scaffold-compatible sequence variation in the triple-hairpin structure of human imunodeficiency virus type 1 gp41 with patient data. J Virol (2002) 0.77
Genomic Diversity of Human Immunodeficiency Viruses. Med J Armed Forces India (2011) 0.75
Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon. Retrovirology (2017) 0.75
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science (1984) 33.32
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science (1984) 32.33
Nucleotide sequence of the AIDS virus, LAV. Cell (1985) 16.81
Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science (1984) 15.82
Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science (1984) 11.30
Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science (1984) 10.40
Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science (1985) 9.27
Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell (1986) 9.01
Isolation of a new human retrovirus from West African patients with AIDS. Science (1986) 7.97
Identification of a putative regulator of early T cell activation genes. Science (1988) 6.62
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. Science (1985) 6.31
AIDS in Africa: an epidemiologic paradigm. Science (1986) 5.88
Genomic diversity of human T-lymphotropic virus type III (HTLV-III). Science (1985) 5.33
Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. Science (1987) 5.22
Effects of the modification of transfer buffer composition and the renaturation of proteins in gels on the recognition of proteins on Western blots by monoclonal antibodies. Anal Biochem (1986) 4.91
Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol Cell Biol (1988) 4.33
Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J (1989) 4.24
Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus. EMBO J (1987) 4.14
Regulation of human interleukin-2 gene: functional DNA sequences in the 5' flanking region for the gene expression in activated T lymphocytes. Cell (1986) 3.88
Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates. Int J Cancer (1988) 3.60
Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals. J Infect Dis (1985) 3.31
Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1. EMBO J (1988) 2.74
Characterization of long terminal repeat sequences of HTLV-III. Science (1985) 2.56
Comparison of simian immunodeficiency virus isolates. Nature (1988) 2.55
Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet (1986) 2.48
Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. J Virol (1986) 2.40
Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J Immunol (1989) 2.21
Isolation and characterization of simian immunodeficiency virus from mandrills in Africa and its relationship to other human and simian immunodeficiency viruses. J Virol (1988) 2.17
Regulation of interleukin 2 receptor alpha subunit (Tac or CD25 antigen) gene expression: binding of inducible nuclear proteins to discrete promoter sequences correlates with transcriptional activation. Proc Natl Acad Sci U S A (1988) 1.74
HIV-2, the West African AIDS virus. AIDS (1987) 1.35
Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding. Proc Natl Acad Sci U S A (1988) 1.19
Cross-reactivity to human T-lymphotropic virus type III/lymphadenopathy-associated virus and molecular cloning of simian T-cell lymphotropic virus type III from African green monkeys. Proc Natl Acad Sci U S A (1986) 1.06
Selective cytotoxicity of AIDS virus infection towards HTLV-I-transformed cell lines. Int J Cancer (1985) 0.88
Isolation of human immunodeficiency virus type 2 from a homosexual man in Belgium. Eur J Clin Microbiol Infect Dis (1988) 0.87
HIV infection in Nigeria. AIDS (1988) 0.84
Virus related to but not identical with LAV/HTLV-III in Cameroon. Lancet (1986) 0.84
Genomic variability of selected LAV-related AIDS retroviruses. AIDS Res (1986) 0.79
Complete structure of the hemagglutinin gene from the human influenza A/Victoria/3/75 (H3N2) strain as determined from cloned DNA. Cell (1980) 14.28
CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol (1994) 6.67
Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol (1993) 5.26
Antigenic drift between the haemagglutinin of the Hong Kong influenza strains A/Aichi/2/68 and A/Victoria/3/75. Nature (1980) 5.25
Nucleotide sequence of a 16S ribosomal RNA gene from Neisseria gonorrhoeae. Nucleic Acids Res (1988) 4.19
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial. Gut (2000) 2.55
Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol (1995) 2.48
Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol (1994) 2.29
Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect Immun (1998) 2.12
Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut (1999) 1.91
Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24gag. Virology (1989) 1.91
Sequence analysis of a highly divergent HIV-1-related lentivirus isolated from a wild captured chimpanzee. Virology (1996) 1.91
Genotypic subtypes of HIV-1 in Cameroon. AIDS (1994) 1.89
Rapid identification of Mycobacteria to the species level using INNO-LiPA Mycobacteria, a reverse hybridization assay. J Clin Microbiol (2001) 1.85
Expression of human fibroblast interferon gene in Escherichia coli. Nature (1980) 1.72
Geographical distribution of HIV-1 group O viruses in Africa. AIDS (1997) 1.71
Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients. J Clin Microbiol (2000) 1.70
Evaluation of recombinant dense granule antigen 7 (GRA7) of Toxoplasma gondii for detection of immunoglobulin G antibodies and analysis of a major antigenic domain. Clin Diagn Lab Immunol (1999) 1.61
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology (2000) 1.55
Intracellular phosphorylation of broad-spectrum anti-DNA virus agent (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and inhibition of viral DNA synthesis. Mol Pharmacol (1987) 1.49
Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. J Acquir Immune Defic Syndr (2000) 1.47
Isometric maximal and submaximal trunk extension at different flexed positions in standing. Triaxial torque output and EMG. Spine (Phila Pa 1976) (1993) 1.45
DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun (2000) 1.44
Multivariate analysis of human immunodeficiency virus type 1 neutralization data. J Virol (1996) 1.41
Molecular cloning, nucleotide sequence, and occurrence of a 16.5-kilodalton outer membrane protein of Brucella abortus with similarity to pal lipoproteins. Infect Immun (1994) 1.39
Humoral immune responses of Brucella-infected cattle, sheep, and goats to eight purified recombinant Brucella proteins in an indirect enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (1997) 1.39
Genetic and phylogenetic analysis of env subtypes G and H in central Africa. AIDS Res Hum Retroviruses (1994) 1.34
Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K. AIDS Res Hum Retroviruses (2000) 1.33
Risk factors for acquisition of hepatitis C virus infection in blood donors: results of a case-control study. Gastroenterology (1999) 1.31
Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates. J Med Virol (2000) 1.31
Identification and heterologous expression of a new dense granule protein (GRA7) from Toxoplasma gondii. Mol Biochem Parasitol (1998) 1.27
Isolation of simian immunodeficiency viruses from two sooty mangabeys in Côte d'Ivoire: virological and genetic characterization and relationship to other HIV type 2 and SIVsm/mac strains. AIDS Res Hum Retroviruses (1994) 1.25
Cloning, nucleotide sequence, and expression of the Brucella melitensis bp26 gene coding for a protein immunogenic in infected sheep. FEMS Microbiol Lett (1996) 1.22
Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial. Hepatology (1987) 1.22
Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. J Virol (1999) 1.22
Coping and the ineffectiveness of coping influence the outcome of in vitro fertilization through stress responses. Psychoneuroendocrinology (1992) 1.22
Phylogenetic analysis of a new chimpanzee lentivirus SIVcpz-gab2 from a wild-captured chimpanzee from Gabon. AIDS Res Hum Retroviruses (1994) 1.21
Cloning and sequence analysis of a newly identified Brucella abortus gene and serological evaluation of the 17-kilodalton antigen that it encodes. Clin Diagn Lab Immunol (1995) 1.18
Identification of numerous hepatitis C virus genotypes in Montreal, Canada. J Clin Microbiol (1996) 1.14
A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology (1994) 1.12
TLR-2 and TLR-9 are sensors of apoptosis in a mouse model of doxorubicin-induced acute inflammation. Cell Death Differ (2011) 1.11
Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D. AIDS Res Hum Retroviruses (1995) 1.10
Smokers can learn to influence their urge to smoke. Addict Behav (2000) 1.09
Antigenic evidence of the presence of the aberrant HIV-1ant70 virus in Cameroon and Gabon. AIDS (1993) 1.09
Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes. J Virol Methods (1997) 1.08
The diagnostic value of nipple discharge cytology in 618 consecutive patients. Eur J Surg Oncol (2008) 1.08
Isolation of HIV-1 RNA from plasma: evaluation of seven different methods for extraction (part two). J Virol Methods (1998) 1.08
Molecular characterization, occurrence, and immunogenicity in infected sheep and cattle of two minor outer membrane proteins of Brucella abortus. Infect Immun (1996) 1.08
The functioning of the SRP receptor FtsY in protein-targeting in E. coli is correlated with its ability to bind and hydrolyse GTP. FEBS Lett (1995) 1.05
Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses. J Infect Dis (1995) 1.04
Genetic variation of HIV type 1: relevance of interclade variation to vaccine development. AIDS Res Hum Retroviruses (1998) 1.04
Biological and clinicopathological features associated with hepatitis C virus type 5 infections. J Hepatol (1996) 1.04
Redistribution of a murine humoral immune response following removal of an immunodominant B cell epitope from a recombinant fusion protein. Mol Immunol (1993) 1.02
A.I.D.-couples: psychological and psychopathological evaluation. Andrologia (1975) 1.01
Modeling HIV transfer between dendritic cells and T cells: importance of HIV phenotype, dendritic cell-T cell contact and T-cell activation. AIDS (2000) 1.00
Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals. Antimicrob Agents Chemother (1999) 0.99
Genetic variability of HIV type 1 in Kenya. AIDS Res Hum Retroviruses (1994) 0.99
The sarco-endoplasmic reticulum Ca2+ ATPase is required for development and muscle function in Caenorhabditis elegans. J Biol Chem (2001) 0.99
Molecular phylogeny of part of the env gene of HIV-1 strains isolated in Côte d'Ivoire. AIDS (1994) 0.98
Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study. Am J Gastroenterol (1999) 0.98
HIV-1 subtypes and the HIV epidemics in four cities in sub-Saharan Africa. AIDS (2001) 0.97
Further evidence of the presence of genetically aberrant HIV-1 strains in Cameroon and Gabon. AIDS (1994) 0.96
beta-D-xylosidase from Bacillus pumilus. Methods Enzymol (1982) 0.95
Assessment of a new immunoassay for serological confirmation and discrimination of human T-cell lymphotropic virus infections. Clin Diagn Lab Immunol (1998) 0.95
Visual determinants of reduced performance on the Stroop color-word test in normal aging individuals. J Clin Exp Neuropsychol (2001) 0.95
Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assay. J Virol Methods (1998) 0.95
Use of the 5' noncoding region for genotyping hepatitis C virus. J Infect Dis (1994) 0.95
Presinusoidal portal hypertension in non-alcoholic cirrhosis. Hepatology (1985) 0.95
Inhibition of herpes simplex virus DNA polymerase by diphosphates of acyclic phosphonylmethoxyalkyl nucleotide analogues. Antiviral Res (1990) 0.94
The urge to smoke depends on the expectation of smoking. Addiction (2002) 0.94
Recombinant staphylokinase variants with altered immunoreactivity. I: Construction and characterization. Circulation (1996) 0.93
Ankle-Knee prosthesis with powered ankle and energy transfer for CYBERLEGs α-prototype. IEEE Int Conf Rehabil Robot (2013) 0.93
Human cyclophilin has a significantly higher affinity for HIV-1 recombinant p55 than p24. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.93
Study of HIV type 1 gag/env variability in The Gambia, using a multiplex DNA polymerase chain reaction. AIDS Res Hum Retroviruses (2000) 0.93
Hepatitis B virus: genotypes and subtypes in Brazilian hemodialysis patients. Artif Organs (1999) 0.90
Epidemiological and molecular characteristics of HIV infection in Gabon, 1986-1994. AIDS (1996) 0.90
Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant. J Virol (1997) 0.89
Transjugular intrahepatic portacaval stent shunt as a rescue treatment for life-threatening variceal bleeding in a cirrhotic patient with severe liver failure. Am J Gastroenterol (1992) 0.89
Broad-spectrum antiviral activity of carbodine, the carbocyclic analogue of cytidine. Biochem Pharmacol (1990) 0.89
Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group O. J Med Virol (1997) 0.89
Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing. AIDS (1998) 0.89
Psychological aspects of chronic pelvic pain in women. Am J Obstet Gynecol (1979) 0.89
Effect of methodology on detection of HIV-1/HIV-2 dual infections in Côte d'Ivoire. J Virol Methods (1994) 0.88
Intrapatient variability of HIV type 1 group O ANT70 during a 10-year follow-up. AIDS Res Hum Retroviruses (1999) 0.88
Early detection of maedi-visna (ovine progressive pneumonia) virus seroconversion in field sheep samples. J Vet Diagn Invest (2001) 0.87
Diagnosis of HIV-1 group O infection by polymerase chain reaction. Lancet (1995) 0.87
Isolation of human immunodeficiency virus type 2 from a homosexual man in Belgium. Eur J Clin Microbiol Infect Dis (1988) 0.87
Genetic characterization of accessory genes from human immunodeficiency virus type 1 group O strains. AIDS Res Hum Retroviruses (1998) 0.87
Improved detection of HIV-2 proviral DNA in dually seroreactive individuals by PCR. AIDS (1998) 0.87